# Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer

> **NCT04133077** · NA · RECRUITING · sponsor: **Centre Jean Perrin** · enrollment: 85 (estimated)

## Conditions studied

- Breast Cancer Female

## Interventions

- **BIOLOGICAL:** blood samples collection

## Key facts

- **NCT ID:** NCT04133077
- **Lead sponsor:** Centre Jean Perrin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-19
- **Primary completion:** 2030-08-31
- **Final completion:** 2030-08-31
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04133077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04133077, "Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04133077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*